ArticleFrontiers in pharmacology2024

Inhibition of ACOX1 enhances the therapeutic efficacy of obeticholic acid in treating non-alcoholic fatty liver disease and mitigates its lipotoxicity.

Yuping Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.